C-peptide increase in chronic type 1 diabetic patients treated with autologous bone marrow cell transplantation through pancreatic artery catheterization: Three years follow-up

Journals Menu

Follow SCIRP

ISSN Print: 2161-6760
ISSN Online: 2161-6787
www.scirp.org/journal/scd
E-mail: scd@scirp.org

"C-peptide increase in chronic type 1 diabetic patients treated with autologous bone marrow cell transplantation through pancreatic artery catheterization: Three years follow-up"
written by Alejandro Mesples, Shu Jiang, Yun Zhang, Zhaoxia Luo, Xiang Hu,
published by Stem Cell Discovery, Vol.3 No.1, 2013

has been cited by the following article(s):

[1]	Long Term Benefit of Autologous Bone Marrow Stem Cell Transplantation without Immunosuppression in Chronic Type 1 Diabetic Patients
	2020

[2]	Engineering a Clinically Translatable Bioartificial Pancreas to Treat Type I Diabetes
	Trends in Biotechnology, 2018

[3]	Stem Cell Research and Regenerative Medicine
	2018

[4]	Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Mellitus
	Endocrine Pathology, 2015

Follow SCIRP